3 Disappointing Blue Chip Stocks That Have Crashed as Much as 87% in 10 Years

Three Top Blue-Tier Shares That Have Dropped as Much as 87% Over a Decade

In the dynamic world of business, three major companies - Pfizer, Kraft Heinz, and Walgreens Boots Alliance - have faced significant hurdles over the past decade.

Pfizer, a pharmaceutical giant, has seen a decline of more than 19% over the past 10 years, serving as a reminder to investors not to get too caught up in temporary market conditions. Despite this, the company's modest 18 times earnings multiple and a high yield of over 7% suggest that buying Pfizer stock may require patience as a rally may not be coming soon.

Pfizer's recent move to cut costs and make acquisitions, such as the oncology company Seagen in 2023, indicates a strategic shift aimed at turning things around. The company's COVID vaccine and pill resulted in record sales of over $101 billion in 2022, offering a glimmer of hope for its future.

Kraft Heinz, a food and beverage conglomerate, has lost more than 60% of its value over the past decade. The company's sales have been stagnant at around $26 billion for the past four years, and consumers' focus on eating better has led to a decline in popularity for its brands, known for being unhealthy, such as Mac & Cheese. Kraft Heinz is struggling to find ways to grow and pivot toward healthier options.

Walgreens Boots Alliance, a retail pharmacy chain, has been one of the biggest disappointments for investors, down by 87% over the past decade. With consumers buying more goods online, there is less of a need for local Walgreens stores. The company's low profit margins make it difficult to stay out of the red and pay a dividend, and it recently suspended its dividend earlier this year. Walgreens is going private at a purchase price of $11.45, but remains a risky business to invest in.

Investors have been cautious about buying Pfizer and Walgreens Boots Alliance stock due to concerns about government cutbacks on healthcare spending and a declining COVID market, respectively. Meanwhile, Kraft Heinz's major shareholders include activist firm Elliott Management, known for challenging the company's management and strategic direction. The principal shareholders of Kraft Heinz and Pfizer, such as Invesco Ltd. and institutional investors, are not explicitly detailed in the search results provided.

In conclusion, Pfizer, Kraft Heinz, and Walgreens Boots Alliance have faced challenging times over the past decade. However, with strategic shifts and potential growth opportunities, there is still hope for these companies to turn things around. Investors should approach these stocks with patience and a long-term perspective.